Mulard, FR
Denis Mulard, Paris FR
Patent application number | Description | Published |
---|---|---|
20140012454 | METHOD AND SYSTEM FOR TIMETABLE OPTIMIZATION UTILIZING ENERGY CONSUMPTION FACTORS - Embodiments relate to systems and methods for synchronizing two or more railway assets to optimize energy consumption. For example, an embodiment of the present invention provides receipt of a timetable associated with two or more vehicles and at least one terminal. The timetable can be modified to create a modified timetable that overlaps a brake time for a first vehicle and an acceleration time for a second vehicle, wherein at least one of a departure time or a dwell time is modified. Furthermore, the second vehicle can transfer energy from the first vehicle based upon at least one of the modified timetable and the brake time overlapping with the acceleration time. | 01-09-2014 |
20140180510 | METHOD AND SYSTEM FOR TIMETABLE OPTIMIZATION UTILIZING ENERGY CONSUMPTION FACTORS - Systems and methods for synchronizing two or more vehicles operating on an electric transportation line to optimize energy consumption. A controller is provided having a computer memory component storing a set of computer-executable instructions, a list of braking intervals, and a list of acceleration intervals for the vehicles. The controller also has a processing component configured to execute the set of computer-executable instructions to operate on the list of braking intervals and the list of acceleration intervals to minimize an energy consumption of the electric transportation line over a determined period of time by shifting acceleration intervals to synchronize with braking intervals. A dedicated heuristic greedy algorithm and an energy model are implemented in the controller as part of the computer-executable instructions to achieve the improved energy consumption. | 06-26-2014 |
Laurence Mulard, Le Kremlin Bicetre FR
Patent application number | Description | Published |
---|---|---|
20080293620 | Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections - A method for diagnosing an infection in a patient likely to be infected with a pathogenic microorganism, comprising the detection of CD4+ T lymphocytes recognizing at least one glycopeptide derived from said pathogenic microorganism, essentially consisting of a glycosylated T epitope, comprising from 14 to 25 amino acids, among which at least one neutral amino acid is bonded to a disaccharide or to a trisaccharide, and at least 15% of said amino acids are prolines, one of the prolines being located in position −1 to −4, relative to the position of said neutral amino acid. | 11-27-2008 |
20100239584 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3A AND X - The present invention relates to compounds derived from sugars which reproduce the epitopes of | 09-23-2010 |
20110086767 | MUTANTS OF GLYCOSIDE HYDROLASES AND USES THEREOF FOR SYNTHESIZING COMPLEX OLIGOSACCHARIDES AND DISACCHARIDE INTERMEDIATES - Method for preparing the disaccharide α-D-glucopyranosyl-(1→4)-2-N-acetyl-2-deoxy-α-D-glucopyranoside, comprising the step of using a mutant of a wild type glycoside hydrolase. | 04-14-2011 |
20110144317 | MUTANTS OF GLYCOSIDE HYDROLASES AND USES THEREOF FOR SYNTHESIZING COMPLEX OLIGOSACCHARIDES AND DISACCHARIDE INTERMEDIATES - Method for preparing the disaccharide [α-D-Gldp(1→3)]-α-L-Rhap-YR wherein Y is selected from —O— and —S— and R is selected from the group consisting of: C | 06-16-2011 |
20130243751 | GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI - A conjugate molecule comprising an oligo- or polysaccharide covalently bound to a carrier and its use as potential vaccine against infection by | 09-19-2013 |
20140161793 | GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI - A conjugate molecule comprising an oligo- or polysaccharide covalently bound to a carrier and its use as potential vaccine against infection by | 06-12-2014 |
20150050282 | GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3a AND X - The present invention relates to compounds derived from sugars which reproduce the epitopes of | 02-19-2015 |